Results 131 to 140 of about 330,731 (313)
Clinical Model‐Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients
Clinical Pharmacology &Therapeutics, EarlyView.Traditional dosing strategies often rely on a “one‐size‐fits‐all” paradigm, assuming an “average” patient with typical demographic and pharmacological characteristics. In reality, this often overlooks existing between‐patient variability and can lead to suboptimal drug exposure or toxicity. This issue is especially pronounced in pediatric patients, who Zachary L. Taylor, Takanobu Nadai, Kei Irie, Wen Rui Tan, Sanjana Parikh, Anhar Hosawi, Matthijs W. van Hoogdalem, Ronaldo Morales Junior, Sonya Tang Girdwood, Abbie D. Leino, Kana Mizuno, Alexander A. Vinks, Tomoyuki Mizuno +12 morewiley +1 more sourceNAFLD/MASLD, including cirrhosis: Burden from 1990 to 2040, GBD decomposition, CDC WONDER analysis, and machine-learning attribution
Luna Zhao, Bingjie Li, Xi Zhang, Jinbao Liu, Jingkun Li, Hanwen Zhang, Kexin Cui, Junhao Ma, Fangyi Zhao, 朱庆峰 +9 moreopenalex +1 more sourcePharmacokinetics of Rifapentine and Desacetyl Rifapentine in Maternal Plasma and Breast Milk & Infant Cord Blood and Plasma: A Model‐Based Analysis of Mother–Infant Pairs for Tuberculosis Prevention
Clinical Pharmacology &Therapeutics, EarlyView.IMPAACT 2001 (NCT02651259) evaluated the safety and pharmacokinetics (PK) of once‐weekly isoniazid and rifapentine in pregnant and postpartum women for tuberculosis prevention. Rifapentine (RPT) and desacetyl rifapentine (desRPT) PK data were collected in maternal plasma, breast milk, infant cord blood, and infant plasma.Priya Jayachandran, Jyoti S. Mathad, Nan Zhang, Paula Britto, Lubbe Wiesner, Grace Montepiedra, Jennifer Norman, Ellen Townley, Sarah Bradford, Sandesh Patil, Stephanie Popson, Tsungai Chipato, Vanessa Rouzier, Deborah Langat, Amphan Chalermchockcharoentkit, Amita Gupta, Kelly E. Dooley, Radojka Savic, on behalf of the IMPAACT 2001 Study Team +18 morewiley +1 more sourceImmunotherapy in Bellini Duct Carcinoma: A Systematic Review. [PDF]
Oncol ResLázaro-Sánchez AD, Benítez-Fuentes JD, Wikström-Fernández S, Nevado-Rodríguez M, Conesa-Zamora P, Luengo-Gil G, Ivars-Rubio A, Zafra-Poves M, Carosella ED, Fernández-Molina B, Nieto-Olivares A, Sánchez de Las Matas Garre MJ, Arroyo AB. +12 moreeuropepmc +1 more sourceProportion, Five‐Year Survival Rate of Laryngeal Cancer and Its Associated Factors Among Head and Neck Cancer Patients in Tanzania
Eye &ENT Research, EarlyView.ABSTRACT Background
Laryngeal cancer carries a significant global burden, with substantial morbidity and mortality, and is increasing globally, with 95%–98% being squamous cell carcinoma. Males are more affected than females, with peak cases occurring between 60 and 80 years of age.Amenye Adili, Furaha Serventi, Baraka M. Musimu, Mica Magembe, Orest Tarimo, Geofrey Ikelesho, Salum Kalonge, Leonard Kiboko, Queen Godfrey Tarimo, Desderius C. Chussi +9 morewiley +1 more sourceTreatment and outcome of chronic disseminated candidiasis in the era of antifungal prophylaxis: a retrospective multicentre cohort of 111 patients. [PDF]
EClinicalMedicineReinhold I, Ramirez-Sanchez IC, Chen PY, Chen YC, Dhariwal A, Lambourne J, Agrawal S, Bastida M, Gudiol C, Alfandari S, Di Pilla A, Khostelidi S, Aguilar-Zapata D, Barac A, Cipriano A, Ehrlich S, Grothe J, Illarramendi J, Jennrich S, Khedr R, Leotta D, Méndez GA, Nacov JA, Nagao M, Saydam G, Schwartz S, Steinmann J, Arn K, Enoch DA, Föhring D, Joean O, Koehler P, Krause R, Maertens J, Marchesi F, Onyeaghala C, Stone N, Vanbiervliet Y, Wolfensberger N, Haensel L, Hurraß J, Panse J, Sal E, Stemler J, Bové DS, Sprute R, Minero MV, Vena A, Pagano L, Cornely OA, Seidel D, FungiScope® Working Group of the European Confederation of Medical Mycology (ECMM) and the International Society for Human and Animal Mycology (ISHAM);, Fungal Infections Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG) and the ESCMID Study Group for Infections in Compromised Hosts (ESGICH). +52 moreeuropepmc +1 more sourceCardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study
ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.Abstract Aims
Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia +17 morewiley +1 more source